Navigation Links
AutoImmune Inc. Reports 2008 Second Quarter Financial Results
Date:8/7/2008

PASADENA, Calif., Aug. 7 /PRNewswire-FirstCall/ -- AutoImmune Inc. (OTC Pink Sheets: AIMM) today reported a net loss of $86,000, or $0.01 per share basic and diluted, for the three months ended June 30, 2008, compared with a net loss of $62,000, or break even per share basic and diluted, for the three months ended June 30, 2007. For the six months ended June 30, 2008, the net loss was $193,000, or $0.01 per share basic and diluted, compared with net loss of $54,000, or break even per share basic and diluted for the same period in 2007. As of June 30, 2008, the Company reported $8.6 million in cash and marketable securities as compared to $8.8 million in cash and marketable securities as of December 31, 2007.

Chairman of the Board and Chief Executive Officer Robert C. Bishop, Ph.D. stated, "Product sales at Colloral LLC met our expectations during the second quarter." AutoImmune consolidates Colloral LLC for financial reporting purposes in accordance with FIN 46 "Consolidation of Variable Interest Entities."

AutoImmune has exclusively licensed certain of its intellectual property rights to BioMS Medical Corp., a Canadian company. Under the license agreement, BioMS makes monthly diligence payments to AutoImmune and will pay royalties to AutoImmune on sales of its lead drug MBP8298, if it reaches the market. BioMS sublicensed its rights in this product to Eli Lilly and Company and subsequently stated that the only results they expect to release in 2008 from an upcoming interim analysis on the first 200 patients in its pivotal phase II/III trial evaluating MBP8298 for treatment of secondary progressive multiple sclerosis will be those related to safety and/or futility. A full analysis of the trial data should be available during the second half of 2009.

AutoImmune is a biopharmaceutical company involved in the development of treatments for autoimmune and cell-mediated inflammatory diseases and conditions.

Statements in this release tha
'/>"/>

SOURCE AutoImmune Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. AutoImmune Inc. Reports 2007 Fourth Quarter and Year End Financial Results
2. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes - Correction
3. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes
4. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
5. Isis Reports Financial Results and Highlights for Second Quarter of 2008
6. Barr Reports Second Quarter 2008 GAAP Earnings of $0.52 Per Share; Adjusted Earnings of $0.64 Per Share
7. PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results
8. Caliper Life Sciences Reports Second Quarter 2008 Results
9. Watson Pharmaceuticals Reports Second Quarter 2008 Results
10. EntreMed Reports Second Quarter 2008 Financial Results
11. Transgenomic Reports Second Quarter 2008 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... METTLER TOLEDO recently ann...free webinar, “The Role of Process Analytica...gineering” on December 1, 2009. , ... the The Role of Process Analytical Technology (P...ar on December 1, Process Analytical Technology (...
(Date:11/19/2009)... , BLAUVELT, N.Y., Nov. 19 Dr... germ extract, responds to a press release issued ... Hungarian company for making false and self-servi...ioSciences. ,, Dr. Hidvegi stated from his off...laim that research on Avemar does not apply to Ave...
(Date:11/19/2009)... , MALVERN, Pa. and WALTHAM, Mass., Nov. ...R) and Decision Resources find that the leading dr...ia in Europe is broad-spectrum activity against gr...e variety of organisms that can cause nosocomial p... they look primarily for agents that provide appro...
(Date:11/19/2009)... World,s Top Gene Synthesis ...tium (IGSC) to Coordinate Best Practices in Risk R...cent of Worldwide Gene Synthesis Capacity , ...ve of the world’s leading gene synthesis com...ply a common screening protocol to promote biosecu...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
...harmaceutical Inc. (Nasdaq: BMRN ) today announce...cer of BioMarin, will present a company,update at ... New York City,on Tuesday, September 9, 2008 at 1:... audio webcast of the conference,call via the inve...BMRN.com .,A replay of the call will be archived o...
...signs, Inc., a,leading provider of immunoassay kit...nd translational research markets, has launched a ...velopment kits called ImmunoSet(TM).,This cost eff...various,matrices contains the basic components and...rimetric enzyme immunoassays. Assay Designs has an...
...sX, Inc.,(Nasdaq: NGSX ), a biopharmaceutical com...el pain management therapies, announced today that...ficer, is scheduled to,present at the Morgan Stanl...ork City on Tuesday, September 9, 2008. Mr. DiTonn...ill be available to respond to questions during,th...
Other Biology Technology:BioMarin to Present at the Morgan Stanley Global Healthcare Conference 2NeurogesX to Present at Morgan Stanley Global Healthcare Unplugged Conference 2NeurogesX to Present at Morgan Stanley Global Healthcare Unplugged Conference 3
(Date:11/23/2009)...General Medical Sciences (NIGMS), part of the Nati...3 million for grants in scientific areas it identi...the GO grant program to stimulate biomedical resea...erican Recovery and Reinvestment Act (Recovery Act...o have a significant impact on a field of biomedic...
(Date:11/23/2009)... Telethon Institute for Child Health Research has ...ol consumption in pregnancy affects child behaviou...ublished online in the international journal Addi...nalysis was drawn from a random sample of more tha... months after the baby,s delivery, and were then f...
(Date:11/23/2009)... is Director of the Interuniversity Professorship ...and the University of the Basque Country. The Prof...as other experts such as researchers in the fields...ts in ethics. , The Interuniversity Professorshi... of Deusto and the Basque Country was created in 1...
Breaking Biology News(10 mins):NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3New study links alcohol in pregnancy to child behavior problems 2Research and legislation should go hand in hand, as much as possible 2New chemistry techniques improve hybrid scanner performance 48911 1New chemistry techniques improve hybrid scanner performance 48911 2NASAC statement on the occasion of the G8+5 Summit in LAquila Italy 48907 1NASAC statement on the occasion of the G8+5 Summit in LAquila Italy 48907 2New Online Community Answers Hospital Questions about ARRA QHR Announces Launch of theQsphere com 48903 1New Online Community Answers Hospital Questions about ARRA QHR Announces Launch of theQsphere com 48903 2
...al Society of America (ESA) is pleased to announce...fessional awards will be presented at the 2008 Ann...sion from 5:30-7:30 p.m. on the evening of Sunday,...sented from 6:30-7:30 p.m. on Tuesday, November 18... Entomological Foundation,s awards and scholarship...
...where. They are used in cancer treatments, automob... hydrogen gas production. However, until recently,...out producing synthetic chemicals that had negativ...d by a University of Missouri research team, not o...but also has resulted in national and internationa...
...ransmitting compound that could one day be used in...tect biological and chemical weapons at long dista... its structure was too difficult to examine. , Lu... Argonne National Laboratory and Northwestern Univ... compound using the uniquely suited Chemistry and ...
Other Biology News:Entomological Society of America names 2008 award winners 2Entomological Society of America names 2008 award winners 3Entomological Society of America names 2008 award winners 4Entomological Society of America names 2008 award winners 5Entomological Society of America names 2008 award winners 6Entomological Society of America names 2008 award winners 7Entomological Society of America names 2008 award winners 8Entomological Society of America names 2008 award winners 9Entomological Society of America names 2008 award winners 10Entomological Society of America names 2008 award winners 11Entomological Society of America names 2008 award winners 12Entomological Society of America names 2008 award winners 13MU scientists go green with gold, distribute environmentally friendly nanoparticles 2Argonne scientists peer into heart of compound that may detect chemical, biological weapons 2
...alance increases your lab productivity and allows ...atory compliance. Move ahead beyond traditional pa...ecure networked data system. *Instruments support...G, XS, XP, PR, SR, PG-S, PG, SG, AT, MT, UMT, AB-S...
...urification Kits enable rapid analytical to medium...ns produced from appropriate vectors. Sufficient r...g target protein under native or denaturing condit...garose, which specifically retains STag fusion pro...
Baker's yeast (S. cerevisiae) Hexokinase and glucose-6-phosphate dehydrogenase from Sigma-Aldrich
... Polyclonal Antibody Epitope: aa 16-25 of huma...Recommended Storage: Store vial at -20 C prior to... extended storage aliquot contents and freeze at -...ng. Family: Other Sub-Family: not assigned...
Biology Products: